U.S. Markets closed

Novavax (NVAX) in Focus: Stock Tumbles 8.3%

Zacks Equity Research

Novavax (NVAX) saw a big move last session, as the company’s shares fell by over 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for NVAX, as the stock is now up nearly 12% in the past one-month time frame.

The company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks. There has been no estimate revision on either side, though the consensus for loss estimates has widened marginally. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

NVAX currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the health care sector include Actelion Ltd. (ALIOF), Affymetrix Inc. (AFFX) and Emergent BioSolutions, Inc. (EBS). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

(NVAX): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report


Zacks Investment Research